
浏览全部资源
扫码关注微信
纸质出版日期:2017
移动端阅览
黄海烽, 王春花, 赵玲璐, 等. 丹酚酸B抑制血管紧张素Ⅱ诱导心肌成纤维细胞增殖与分化的作用[J]. 中国实验方剂学杂志, 2017,23(13):128-132.
HUANG Hai-feng, WANG Chun-hua, ZHAO Ling-lu, et al. Effect of Salvianolic Acid B in Inhibiting Angiotensin Ⅱ-induced Proliferation and Differentiation of Rat Cardiac Fibroblast[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(13): 128-132.
黄海烽, 王春花, 赵玲璐, 等. 丹酚酸B抑制血管紧张素Ⅱ诱导心肌成纤维细胞增殖与分化的作用[J]. 中国实验方剂学杂志, 2017,23(13):128-132. DOI: 10.13422/j.cnki.syfjx.2017130128.
HUANG Hai-feng, WANG Chun-hua, ZHAO Ling-lu, et al. Effect of Salvianolic Acid B in Inhibiting Angiotensin Ⅱ-induced Proliferation and Differentiation of Rat Cardiac Fibroblast[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(13): 128-132. DOI: 10.13422/j.cnki.syfjx.2017130128.
目的:研究丹酚酸B(salvianolic acid B,Sal-B)对血管紧张素Ⅱ(angiotensin Ⅱ,AngⅡ)诱导的新生SD大鼠心肌成纤维细胞(cardiac fibroblasts,CFs)增殖与分化的影响,探讨Sal-B是否具有对抗心肌纤维化的作用。方法:胰酶消化,差速贴壁分离纯化CFs,抗波形蛋白免疫细胞化学法鉴定CFs。建立AngⅡ诱导的CFs增殖分化模型。实验分为空白组(无血清DMEM),模型组(1×10-6 mol·L-1 AngⅡ),Sal-B低剂量组(2.5×10-5 mol·L-1 Sal-B+1×10-6 mol·L-1 AngⅡ)及Sal-B高剂量组(5×10-5 mol·L-1 Sal-B+1×10-6 mol·L-1 AngⅡ)共4组。Sal-B预保护1 h,加入AngⅡ共同作用24 h后,采用噻唑蓝(MTT)法分析Sal-B对AngⅡ诱导CFs增殖的细胞存活率,采用试剂盒(消化法)测定羟脯氨酸含量,蛋白质免疫印迹(Western blot)分析α-平滑肌肌动蛋白(α-SMA),Ⅰ型胶原(collagenⅠ,ColⅠ)的表达情况。结果:MTT结果显示,与空白组比较,模型组AngⅡ显著诱导CFs异常增殖(P<0.01),与模型组比较,Sal-B低、高剂量显著抑制AngⅡ诱导的CFs增殖(P<0.01);羟脯氨酸含量测定结果显示,与空白组比较,模型组羟脯氨酸含量显著升高(P<0.01),与模型组比较,Sal-B低、高剂量组含量均显著降低(P<0.01);Western blot结果显示,与空白组比较,模型组α-SMA,ColⅠ蛋白表达显著上调(P<0.01),与模型组比较,Sal-B低、高剂量组α-SMA,ColⅠ蛋白表达明显下调(P<0.05,P<0.01)。结论:Sal-B可抑制AngⅡ诱导的CFs增殖,减少α-SMA,ColⅠ蛋白的表达,对AngⅡ体外诱导心肌纤维化进程具有抑制作用。
Objective: To investigate the inhibitory effect of salvianolic acid B (Sal-B) on proliferation and differentiation of cardiac fibroblasts (CFs) induced by angiotensin Ⅱ(Ang Ⅱ) of neonatal Sprague Dawley rats
and clarify the anti-fibrotic mechanism of Sal-B in vitro. Method: Primary CFs were harvested from 1-3-day-old neonatal rats by 0.08% trypsin digesting
and then separated and purified by differential attachment. The CFs were identified by anti-vimentin immunocytochemistry. Proliferation and differentiation of the CFs model were reproduced by Ang Ⅱ. The CFs was randomly divided into 4 groups as follows: normal group (serum-free DMEM)
model group (1×10-6 mol·L-1 Ang Ⅱ)
Sal-B low-dose group (2.5×10-5 mol·L-1 Sal-B+1×10-6 mol·L-1 Ang Ⅱ) and high-dose group (5×10-5 mol·L-1 Sal-B + 1×10-6 mol·L-1 Ang Ⅱ). The CFs were pretreated with Sal-B for 1 h
and then co-cultured with Ang Ⅱ for 24 hours. The inhibition of Sal-B on CFs proliferation was measured by 3-(4
5-dimethyl-2-thiazolyl)-2
5-diphenyl-2H-tetrazolium bromide (MTT) assay. The content of hydroxyproline was detected by commercial kit. The expressions of alpha-smooth muscle actin (α-SMA) and collagen Ⅰ (Col Ⅰ) were detected by Western blot. Result: The results of MTT assay suggested that compared with the normal group
Ang Ⅱ in model group significantly induced abnormal CF proliferation (P<0.01); Compared with model group
both low and high-dose Sal-B significantly inhibited Ang Ⅱ-induced CFs proliferation (P<0.01). The content of hydroxyproline increased in model group (P<0.01) compared with the normal group
but decreased (P<0.01) after being co-cultured with Sal-B compared with model group. Western blot revealed that the expressions of α-SMA and Col Ⅰ significantly increased in the model group (P<0.01)
low-dose and high-dose Sal-B suppressed Ang Ⅱ-induced up-regulation of α-SMA and Col Ⅰ(P<0.05
P<0.01). Conclusion: Sal-B could significantly inhibit Ang Ⅱ-induced cardiac fibroblasts proliferation and expressions of α-SMA and Col Ⅰ
and plays an important role in the process of anti-fibrosis induced by Ang Ⅱ in vitro.
0
浏览量
6
下载量
5
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621